rs28763868

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006063.3(KLHL41):​c.811G>A​(p.Ala271Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.1 in 1,613,940 control chromosomes in the GnomAD database, including 8,852 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A271V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.081 ( 639 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8213 hom. )

Consequence

KLHL41
NM_006063.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.02

Publications

18 publications found
Variant links:
Genes affected
KLHL41 (HGNC:16905): (kelch like family member 41) This gene is a member of the kelch-like family. The encoded protein contains a BACK domain, a BTB/POZ domain, and 5 Kelch repeats. This protein is thought to function in skeletal muscle development and maintenance. Mutations in this gene have been associated with nemaline myopathy (NM), a rare congenital muscle disorder. [provided by RefSeq, Mar 2015]
KLHL41 Gene-Disease associations (from GenCC):
  • nemaline myopathy 9
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016920269).
BP6
Variant 2-169510589-G-A is Benign according to our data. Variant chr2-169510589-G-A is described in ClinVar as Benign. ClinVar VariationId is 259911.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.111 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLHL41NM_006063.3 linkc.811G>A p.Ala271Thr missense_variant Exon 1 of 6 ENST00000284669.2 NP_006054.2 O60662-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLHL41ENST00000284669.2 linkc.811G>A p.Ala271Thr missense_variant Exon 1 of 6 1 NM_006063.3 ENSP00000284669.1 O60662-1
ENSG00000251569ENST00000513963.1 linkc.925-3985G>A intron_variant Intron 11 of 15 2 ENSP00000424363.1 E9PBE3

Frequencies

GnomAD3 genomes
AF:
0.0810
AC:
12315
AN:
152026
Hom.:
640
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0356
Gnomad AMI
AF:
0.0989
Gnomad AMR
AF:
0.0664
Gnomad ASJ
AF:
0.0686
Gnomad EAS
AF:
0.0142
Gnomad SAS
AF:
0.0831
Gnomad FIN
AF:
0.108
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.113
Gnomad OTH
AF:
0.0770
GnomAD2 exomes
AF:
0.0857
AC:
21553
AN:
251440
AF XY:
0.0882
show subpopulations
Gnomad AFR exome
AF:
0.0386
Gnomad AMR exome
AF:
0.0485
Gnomad ASJ exome
AF:
0.0712
Gnomad EAS exome
AF:
0.0150
Gnomad FIN exome
AF:
0.108
Gnomad NFE exome
AF:
0.113
Gnomad OTH exome
AF:
0.0911
GnomAD4 exome
AF:
0.102
AC:
149111
AN:
1461796
Hom.:
8213
Cov.:
33
AF XY:
0.101
AC XY:
73802
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.0344
AC:
1153
AN:
33478
American (AMR)
AF:
0.0507
AC:
2266
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0750
AC:
1961
AN:
26136
East Asian (EAS)
AF:
0.00786
AC:
312
AN:
39700
South Asian (SAS)
AF:
0.0763
AC:
6582
AN:
86252
European-Finnish (FIN)
AF:
0.108
AC:
5780
AN:
53420
Middle Eastern (MID)
AF:
0.0671
AC:
387
AN:
5768
European-Non Finnish (NFE)
AF:
0.113
AC:
125173
AN:
1111926
Other (OTH)
AF:
0.0910
AC:
5497
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
7630
15260
22891
30521
38151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4414
8828
13242
17656
22070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0809
AC:
12310
AN:
152144
Hom.:
639
Cov.:
32
AF XY:
0.0805
AC XY:
5985
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.0356
AC:
1477
AN:
41518
American (AMR)
AF:
0.0663
AC:
1014
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0686
AC:
238
AN:
3468
East Asian (EAS)
AF:
0.0143
AC:
74
AN:
5182
South Asian (SAS)
AF:
0.0832
AC:
400
AN:
4810
European-Finnish (FIN)
AF:
0.108
AC:
1143
AN:
10566
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.113
AC:
7698
AN:
67992
Other (OTH)
AF:
0.0762
AC:
161
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
589
1178
1768
2357
2946
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0994
Hom.:
3387
Bravo
AF:
0.0753
TwinsUK
AF:
0.116
AC:
429
ALSPAC
AF:
0.115
AC:
443
ESP6500AA
AF:
0.0420
AC:
185
ESP6500EA
AF:
0.112
AC:
959
ExAC
AF:
0.0874
AC:
10613
Asia WGS
AF:
0.0690
AC:
240
AN:
3478
EpiCase
AF:
0.110
EpiControl
AF:
0.113

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nemaline myopathy 9 Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
14
DANN
Benign
0.81
DEOGEN2
Benign
0.015
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.12
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
3.0
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.66
N
REVEL
Benign
0.15
Sift
Benign
0.51
T
Sift4G
Benign
0.55
T
Polyphen
0.0030
B
Vest4
0.044
MPC
0.29
ClinPred
0.0091
T
GERP RS
2.6
Varity_R
0.032
gMVP
0.35
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28763868; hg19: chr2-170367099; COSMIC: COSV52929467; COSMIC: COSV52929467; API